Issues of Recruitment and Rationale for Conducting Clinical Trials on  Mutans Streptococci Suppression in Mothers by Bretz, Walter A. et al.
Hindawi Publishing Corporation
International Journal of Dentistry
Volume 2010, Article ID 107147, 5 pages
doi:10.1155/2010/107147
Clinical Study
Issues of Recruitmentand Rationale for Conducting Clinical
Trials on Mutans Streptococci Suppression in Mothers
Walter A. Bretz,1 OdilaP. S.Rosa,2 SaleteM.B. Silva,2 PatriciaCorby,1
LisaWeissfeld,3 andWalter J. Loesche4
1College of Dentistry, New York University, NY 10010, USA
2Faculdade de Odontologia de Bauru, Universidade de S˜ ao Paulo, 17012-901 Bauru, Brazil
3Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
4School of Dentistry, University of Michigan, Ann Arbor, MI 48109, USA
Correspondence should be addressed to Walter A. Bretz, wb36@nyu.edu
Received 14 March 2010; Revised 5 July 2010; Accepted 8 July 2010
Academic Editor: Jukka H. Meurman
Copyright © 2010 Walter A. Bretz et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The aims of this study are (1) to describe issues related to recruitment of mothers participating in a clinical trial of transmission
of mutans streptococci (MS) from mother to child in Bauru, Brazil and (2) to perform cross-cultural and temporal comparisons
of levels of infection of the MS in mothers of Bauru. A total of 1422 mothers were visited at their domiciles. Cutoﬀ levels for the
MS were established at≥ 105 CFU/mL saliva. The main reason for a mother not enrolling was not being highly infected by the
MS, yet 76% of mothers presented with levels≥ 105 CFU/mL saliva. Recent studies in industrialized countries showed a negative
coeﬃcient for linear tests indicating signiﬁcant decline overtime in the levels of MS in mothers. Intercountry comparisons for
mothers’ salivary levels of the MS with the Bauru study as the reference revealed signiﬁcant diﬀerences with studies conducted in
the last two decades.
1.Introduction
Thirty years ago, Kohler and colleagues demonstrated that
the suppression of high levels of the mutans streptococci
(≥106 colony-forming units (CFU)/mL of saliva) by means
ofcomprehensiveandtailoredregimensdeliveredtomothers
of newly born babies was attainable [1]. This suppression
of high levels of the mutans streptococci (MS) in mothers
resulted in a lower prevalence of the MS and of dental decay
in their children as far as when these children were 7 years of
age, when compared to children of mothers receiving symp-
tomaticdentaltreatment[2,3].Thesehighlevelsofinfection
in mothers in Sweden at that time (1978) would likely not
be found in most communities of industrialized countries
nowadays, probably due to the widespread use of antibiotics,
the use of ﬂuoridated dentifrices, the introduction of dietary
modiﬁers such as sugar substitutes, and public health eﬀorts
[4].
A number of investigators from industrialized countries
have reported the levels of the MS in mothers and/or
pregnant mothers throughout time [5–8]. Nonindustrialized
countries have not fully experienced the beneﬁts of measures
that might interfere with the levels of the MS compatible
with the diagnosis of an infection. In Brazil, high levels of
the MS and of dental caries are still found in children and
adults [9–15].
An inadequate sample can signiﬁcantly alter the end-
points of clinical trials. The studies conducted by Kohler
andcolleaguessuﬀeredfrommethodologicalissuesrelatedto
the design and implementation of clinical trials that include
lack of randomization and of placebo-based groups which
could have potentially biased study results. We have designed
and implemented a randomized double-blind placebo-based
clinical trial to look at the eﬀects of combined chemical
modalities on the suppression of MS in mothers and the
consequences of these eﬀorts on dental caries onset in their
children. To date, there have been no reports describing
issues of recruitment and of comprehensive data reporting
details about potential groups of mothers to be enrolled in
studies of the suppression of MS infections.2 International Journal of Dentistry
The speciﬁc aims of this paper are twofold: (1) to
describe issues related to recruitment of mothers who are
participating in a randomized placebo-based clinical trial on
thepreventionoftransmissionofMSinfectionsfrommother
to child in Bauru, Brazil, and (2) to present a rationale
for conducting these trials by performing cross-cultural and
temporal comparisons of documented levels of infection by
theMSinmothersofBauru,Brazil,withMSlevelspreviously
reported in mothers from industrialized countries.
2.Material&Methods
2.1. Sample Description of Mothers from Bauru, Brazil. A
total of 1422 mothers were initially identiﬁed at a municipal
maternal milk center in the city of Bauru, state of S˜ ao Paulo,
Brazil, between September of 2001 and July of 2003. During
this period, mothers were visited at their domiciles and
invited to participate in the research study in order to apply
eligibility criteria. Those who agreed to be screened signed
a consent form approved by institutional review boards at
the University of Pittsburgh and the Universidade de S˜ ao
Paulo. A total of 693 ﬁrst-time mothers were screened for
MS when their babies were 2 months old. Participants were
predominantly of a low socioeconomic status and were on
a v e r a g e2 0y e a r so l d( r a n g eo f1 6t o3 5y e a r so l d ) .
2.2. Eligibility Criteria. First-time mothers who were the
primary caretakers of the child were invited to participate.
Only mothers who harbored at least 106 CFU of MS per ml
of saliva, as determined by the Dentocult SM Strip Mutans
test(seebelow),wereincludedinthestudy.Eligibilitycriteria
also excluded mothers who (1) had less than 20 teeth, (2)
received ﬂuoride therapy in the previous 3 months, (3) were
taking, on a continual basis, medication that reduces salivary
ﬂow (antidepressants), or required antibiotic prophylaxis
when examined by the dentist, and (4) presented with
cognitive-medical compromise or whose child presented
with similar conditions.
2.3. Mutans Streptococci Salivary Assay. This study employed
the Dentocult SM Strip Mutans test (Orion Diagnostica,
Espoo,Finland)toassesssalivarylevelsoftheMSinmothers.
This assay is a simpliﬁed method that takes advantage of
the MSB medium described by Gold and collaborators [16]
which is traditionally employed to enumerate salivary levels
of the MS. Mothers were asked to chew on paraﬃnf o r1
minute and to discard the excess saliva. Subsequently, two
thirds of an especially treated plastic strip were inserted into
the mouth and rotated on the surface of the tongue about 10
times[17].Thestripwasplacedintoaculturevialcontaining
MSBmediumandprocessedaccordingtothemanufacturer’s
instructions. Results were on a scale of 0 to 3 as follows:
0-1 <105 CFU/mL of saliva, score 2 ≥105-<106 CFU/mL of
saliva, and score of 3 ≥106 CFU/mL of saliva.
2.4. Selection of Studies Reporting on Salivary Levels of
t h eM u t a n sS t r e p t o c o c c ii nM o t h e r s .Selection of studies
for cross-cultural and temporal comparisons was primarily
Table 1: Number of mothers visited, screened, and eligible.
N %
Visited 1422 100%
Screened 693 49% (693/1422)
Eligible 168 24% (168/693)
based on the use of MSB media by the traditional culturing
method or by the Dentocult SM Strip Mutans test. This
is so because this assay employs MSB medium and it has
been shown to yield results highly comparable with the
traditional culturing method that employs MSB medium
[17]. Additional criteria included establishing cutoﬀ levels
of the MS at ≥105 CFU/mL based on the ability to extract
these cutoﬀ levels from existing literature. If we were to
use the cutoﬀ point for the MS of ≥106 CFU/mL of saliva,
comparisons with previous studies would not have been
possible with the exception of the Kohler study.
2.5. Statistical Analysis. Descriptive statistics and statistical
analysis were performed with the use of SAS statistical soft-
ware package (SAS, Cary, North Carolina, USA). An overall
summary measure was computed by the Dersimonian-Laird
test for proportions. A linear test for proportions was
employed to test for trends across time. Z-tests were used to
test for diﬀerences between two proportions.
3. Results
Table 1 shows the number of mothers whose domiciles
were visited, those who were screened, and the number
of eligible mothers. A total of 1422 domiciles were visited
and 693 mothers were initially screened to apply eligibility
criteria. Twenty-four % of mothers (168 of 693) were
eligible to participate and were actually enrolled into the
study. Review of the data revealed the most common issues
for nonenrollment and refusal to participate in the study
(Table 2). The most common reasons for nonenrollment
were not having high salivary levels of the MS, that is, a score
<3 (39.3%), noncontact with potential participants (29.2%),
and mother not being the primary caretaker of the child
(12.3%). The overall refusal rate for the study was 3.7%.
Table 3 presents the prevalence rates for MS salivary
levels ≥105 CFU/mL for the present study and for studies
conducted in the past in industrialized countries. A negative
coeﬃcient for the linear test indicated a signiﬁcant decline
(P<. 0001) in the levels of the MS in mothers overtime;
however the present study was not included in the analysis.
Intercountry comparisons for mothers’ salivary levels of the
mutans streptococci using the study conducted in Bauru
as the reference revealed signiﬁcant diﬀerences with studies
conducted in the late 1980s and 1990s. There were no
signiﬁcant diﬀerences between prevalence rates of the study
conducted in Bauru and studies conducted in the late 1970s.International Journal of Dentistry 3
Table 2: Issues of Nonenrollment and refusal to participate in the study.
Issue N %
Mutans assay score <3 493 39.3%
Mother not home at visit 367 29.2%
Mother not the primary caretaker 155 12.3%
Mother’s address incorrect 93 7.4%
Lack of interest 46 3.7%
Mother wears full-arch prosthesis 32 2.6%
Mother’s domicile not accessible 23 1.8%
Not First-time mother 10 <1%
Mother/child medical compromise 11 <1%
Mother traveling 8 <1%
Fluoride previous 3 months 7 <1%
Mother attending school 3 <1%
Not residing in the domicile 2 <1%
Newborn deceased 2 <1%
Mother leaving Bauru 1 <1%
Mother <20 teeth 1 <1%
Total 1254
Table 3: Studies on the prevalence rates of salivary levels of the mutans streptococci in mothers.
Author/year Country Age of infants Mothers screened (N)
MS
≥105 CFU/mL
Saliva—N (%)
PSTUDY-PBAURU Sig. level
Bauru 2001–06 Brazil 2 mos. 693 525 (76%)
Kohler et al. 1978–81 [1] Sweden 3–8 mos. 249 198 (80%) 4% 0.118
Brown et al. 1984-85 [5] Australia <2 yrs 112 91 (81%) 5% 0.118
Paunio et al. 1986–88 [6] Finland 5–8 mos. 154 77 (50%) −26% <0.0001
Soderling et al. 1991 [8] Finland 3 mos. 338 195 (58%) −18% <0.0001
Brambilla et al. 1993 [7] Italy not born 310 65 (21%) −55% <0.0001
[ ]: reference cited.
4. Discussion
This study is the ﬁrst to report issues related to recruitment
of women into studies aimed at the suppression of MS
infections in mothers. The most common reason for not
enrolling into this study was a mother not presenting with
high salivary levels of the MS (Table 2). Yet, we were still
able to enroll 168 mothers who met eligibility criteria
because of the presence of levels of the MS compatible
with the diagnosis of an infection by these organisms,
that is, >106 CFU/mL of saliva. Unfortunately, we were
unable to assess the recruitment performance of completed
trials aimed at suppressing salivary levels of the mutans
streptococci in mothers.
The refusal rate to participate in this study was very
low (3.7%), whereas studies cited in the medical literature
report refusal rates ranging from 37% to 54% [18]. Given
the fact that this is a population of low socioeconomic
status, this refusal rate is surprising because, based on our
experience, the decision-making process of mothers who
recently delivered may aﬀect willingness to enroll into a
research study. In contrast, since saliva sampling and other
dental-related protocols are likely to be perceived as less
threatening than medical procedures, then the refusal rates
observed in this study are more justiﬁable.
The importance of strategies for the suppression of
MS in mothers for caries prevention in their children has
been long recognized. In the only randomized controlled
clinical trial to test this hypothesis, investigators were unable
to demonstrate an eﬀect of short-term treatment with an
iodine-NaF solution on the transmission of the MS from
mother to child [19]. But the entry level for the mutans
streptococci was >2.5 × 104 CFU/mL of saliva, and, as such,
many of these mothers would not have been qualiﬁed for
participation in the Swedish study conducted successfully by
Kohler and colleagues three decades ago. Thus, the inability
to duplicate the Swedish study could be due to the fact that
the selected mothers were not highly infectious for MS.
These ﬁndings, coupled with observations on the declin-
ing levels of MS in the saliva of subjects from industrialized
countries [20, 21], suggest that studies of the type performed
by the Swedish group would be diﬃcult to perform nowa-
days.TheyprobablycouldnotbeperformedagaininSweden
as the MS levels for teenagers have declined signiﬁcantly in4 International Journal of Dentistry
recent years concomitant with the decline in caries scores
[21]. If this decline, in both the caries rate and the MS
levels, is reﬂectiveof thesituation in industrialized countries,
then interceptive studies are diﬃcult to perform in order to
replicate the Kohler studies, unless they were conducted in
populationsthathavenotrealizedthebeneﬁtsofﬂuoridation
and/or that are highly infected by the MS or unless reemer-
gence of these infections in industrialized countries associ-
ated with ecological or environmental changes may lead to
enhanced exposure and transmission of MS infections. This
latter scenario is evident in studies conducted in Sweden
where adolescent immigrants presented with higher caries
rates than nonimmigrants [22].
Our cohort when compared with cohorts of studies
aimed at determining the salivary levels of the MS showed
that moderate-to-high levels of infection by the MS are still
found nowadays at a high rate (Table 3) in the population of
mothers of Bauru, Brazil. Moderate-to-high infection levels
of the MS in Brazilian mothers are comparable to levels
in mothers where initial interventions for curtailing the
acquisition of MS by infants were conducted three decades
ago. Based on the extensive documentation that mothers
are the primary source of MS for the child [23–26], then
expectant mothers of the city of Bauru would be a suitable
population to perform studies to interfere with the transfer
of MS from mothers to children. Lastly, the high rates of
infection by the MS that are paralleled by high caries rates
in this population make the implementation of clinical trials
focusing on the suppression of salivary levels of the MS
in mothers appealing. This is so because, if these trials
are successful (or not), the results are readily interpretable
and therefore applicable to segments of the population
worldwide where oral health disparities are still a reality.
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